On June 13, 2025, the World Health Organization (WHO) highlighted the rapid spread of the new COVID-19 variant NB.1.8.1, also known as ”Nimbus,” which now accounts for over 37% of cases in the United States, according to recent data. The variant, first identified under monitoring by the WHO, has been detected in at least 13 states, with the Global Initiative on Sharing All Influenza Data (GISAID) database tracking its progression. The WHO is collaborating with health experts to assess the variant’s impact, noting it currently poses a low risk for severe illness but emphasizes the need for continued vigilance. The U.S. Centers for Disease Control and Prevention (CDC) reported that the 2025-2026 vaccines will target the related LP.8.1 variant and will be available this fall, limited to adults 65 and older and individuals aged 12-64 with underlying conditions, marking a shift from routine vaccinations for healthy children and pregnant women. Health and Human Services Secretary Robert F. Kennedy Jr. confirmed this adjustment, though some obstetricians and pediatricians have expressed differing views. The WHO’s monitoring includes data from Europe, the Americas, and the Western Pacific, where NB.1.8.1 has emerged, with no significant changes reported in hospitalizations, ICU admissions, or deaths in Canada despite its presence. The organization continues to provide updates, urging public awareness as the situation develops, with potential implications for global health strategies.
34news.online
34news.online
